This post relates primarily to CAJ, PRY and SHL (and potentially GenesisCare when it seeks listing).
https://theconversation.com/true-blood-cutting-through-confusion-about-pathology-cuts-55140
(law academic perspective on competition)
http://grattan.edu.au/wp-content/uploads/2016/02/935-blood-money.pdf
(health economist perspective, aligned to federal government)
http://www.pathologyaustralia.com.a...alia-Dont-Kill-Bulk-Bill-campaign_final-1.pdf
(private sector campaign release)
Reforms to funding for pathology and diagnostic imaging
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.020(1.35%) |
Mkt cap ! $1.063B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.47 | $1.43 | $2.100M | 1.447M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8500 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 58234 | 3 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| HLS (ASX) Chart |